SAR 6.3
(2.11%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 19.92 Million SAR | -6.09% |
2022 | 21.67 Million SAR | 10.21% |
2021 | 19.88 Million SAR | -3.64% |
2020 | 20.18 Million SAR | 15.06% |
2019 | 17.6 Million SAR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 2.43 Million SAR | 0.0% |
2024 Q1 | 2.43 Million SAR | -84.8% |
2023 Q3 | 3.67 Million SAR | -61.31% |
2023 FY | - SAR | -6.09% |
2023 Q4 | 14.6 Million SAR | 297.16% |
2023 Q2 | 9.5 Million SAR | 108.18% |
2023 Q1 | 4.56 Million SAR | -54.49% |
2022 Q2 | 10.37 Million SAR | 106.99% |
2022 Q1 | 5.01 Million SAR | -55.7% |
2022 FY | - SAR | 10.21% |
2022 Q4 | 10.02 Million SAR | 123.07% |
2022 Q3 | 4.49 Million SAR | -56.66% |
2021 FY | - SAR | -3.64% |
2021 Q4 | 11.31 Million SAR | 108.6% |
2021 Q2 | 7.92 Million SAR | 109.31% |
2021 Q3 | 5.42 Million SAR | -31.59% |
2021 Q1 | 3.78 Million SAR | -62.69% |
2020 Q1 | 4.74 Million SAR | 0.0% |
2020 FY | - SAR | 15.06% |
2020 Q4 | 10.14 Million SAR | 110.83% |
2020 Q3 | 4.81 Million SAR | -51.09% |
2020 Q2 | 9.84 Million SAR | 107.43% |
2019 FY | - SAR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Mouwasat Medical Services Company | 986.81 Million SAR | 97.981% |
Dallah Healthcare Company | 631.92 Million SAR | 96.847% |
National Medical Care Company | 323.02 Million SAR | 93.832% |
Al Hammadi Company For Development and Investment | 438.27 Million SAR | 95.454% |
Middle East Healthcare Company | 551.23 Million SAR | 96.386% |
Dr. Sulaiman Al Habib Medical Services Group Company | 2.54 Billion SAR | 99.217% |
Arabian International Healthcare Holding Company | 111.1 Million SAR | 82.068% |
Future Care Trading Co. | 15.6 Million SAR | -27.648% |
Naba Alsaha Medical Services Company | 65.27 Million SAR | 69.48% |
Lana Medical Co. | 4.56 Million SAR | -336.208% |
Al-Modawat Specialized Medical Co. | 20.76 Million SAR | 4.069% |